Neoangiogenesis in cervical cancer: Focus on CD34 assessment

Romanian Journal of Morphology and Embryology

Volumn 51, Issue 2, 2010, Pages 289-294

  Ancuţa, Codrina ^a   Ancuta E ^b   Zugun Eloae, FL ^a,c   Carasevici, E ^a,c  

^a GRIGORE T POPA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b ALEXANDRU IOAN CUZA UNIVERSITY OF IASI   (Romania)

^c University Hospital Sf Spiridon   (Romania)

Author keywords

Angiogenesis; CD34 antigen; Cervical cancer

Indexed keywords

CD34 ANTIGEN;

ARTICLE; BLOOD VESSEL; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PROGNOSIS; RETROSPECTIVE STUDY; UTERINE CERVIX TUMOR; VASCULARIZATION;

ANTIGENS, CD34; BLOOD VESSELS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; RETROSPECTIVE STUDIES; UTERINE CERVICAL NEOPLASMS;

EID: 77953074746     PISSN: 12200522     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Hatch DK, Fu YS, Cervical and vaginal cancer. In: Berek JS (ed), Novak's Gynecology, Callisto Medical Press, Turkey, 1999, 1111-1155.
2. MAZIBRADA J, RlTTÀ M, MONDINI M, DE ANDREA M, AZZIMONTI B, BORGOGNA C, CIOTTI M, ORLANDO A, Surico N, Chiusa L, Landolfo S, Gariglio M, Interaction between inflammation and angiogenesis during different stages of cervical carcinogenesis, Gynecol Oncol, 2008, 108(1):112-120.
3. KARAVASILIS V, Malamou-Mitsi V, Briasoulis E, Tsanou E, Kitsou E, Kalofonos H, Fountzilas G, Fotsis T, Pavlidis N, Angiogenesis in cancer of unknown primary: clinicopathological study of CD34, VEGF and TSP-1, BMC Cancer, 2005, 5:25.
4. Matthews-Greer J, DeBenedetti A, Tucker A, Dempsey S, Black D, Turbat-Herrera E, A model for angiogenesis in HPV-mediated cervical neoplasia, J Appl Res Clin Exp Ther, 2002, 2(1):77-86.
5. Pilch H, SchÄffer U, Schlenger K, Hawighorst H, Tanner B, Bahlmann F, Höckel M, Kanpstein PG, Angiogenesis in cervical cancer, Gynecol Obstet Fertil, 2000, 28(1):29-37.
6. Abulafia O, Triest WE, Sherer DM, Angiogenesis in squamous cell carcinoma in situ and microinvasive carcinoma of the uterine cervix, Obstet Gynecol, 1996, 88(6):927-932.
7. Bremer GL, Tiebosch AT, van der Putten HW, Schouten HJ, de Haan J, Arends JW, Tumor angiogenesis: an independent prognostic parameter in cervical cancer, Am J Obstet Gynecol, 1996, 174(1 Pt 1):126-131.
8. Kainz C, Speiser P, Wanner C, Obermair A, Tempfer C, Sliutz G, Reinthaller A, Breitenecker G, Prognostic value of tumour microvessel density in cancer of the uterine cervix stage IB to IIB, Anticancer Res, 1995, 15(4):1549-1551.
9. Obermair A, Wanner C, Bilgi S, Speiser P, Kaider A, Reinthaller A, Leodolter S, Gitsch G, Tumor angio-genesis in stage IB cervical cancer: correlation of micro-vessel density with survival, Am J Obstet Gynecol, 1998, 178(2):314-319.
10. Hsu SM, Raine L, Fanger H, Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures, J Histochem Cytochem, 1981, 29(4):577-580.
11. Francu DL, Francu LL, Crauciuc E, Pandeli R, Cozma L, Calin DL, Toma O, The assessment of angiogenesis in the uterine cervix carcinogenesis, Analele ştiinţifice ale Universitǎţii ''Alexandru loan Cuza'' din Iaşi. Secţiunea Geneticǎ şi Biologie Molecularǎ, 2008, IX:11-15.
12. VIEIRA SC, ZEFERINO LC, DA SILVA BB, APARECIDA PlNTO G, Vassallo J, Carasan GAF, De Moraes NG, Quantification of angiogenesis in cervical cancer: a comparison among three endothelial cell markers, Gynecol Oncol, 2004, 93(1):121-124.
13. Vieira SC, Silva BB, Pinto GA, Vassallo J, Moraes NG, Santana JOI, Santos LG, Carvasan GAF, Zeferino LC, CD34 as a marker for evaluating angiogenesis in cervical cancer, Pathol Res Pract, 2005, 201(4):313-318.
14. Lenczewski A, Terlikowski SJ, Sulkowska M, Famulski W, Sulkowski S, Kulikowski M, Prognostic significance of CD34 expression in early cervical squamous cell carcinoma, Folia Histochem Cytobiol, 2002, 40(2):205-206.